We examine areas of the stock market worthy of scrutiny as the new year approaches. Read More
Dr. Joe Duarte is Chief Investment Strategist and Editor of Profit Catalyst Alert and Weekly Cash Machine. He has been a professional investor and independent analyst since 1990. He is a former Registered Investment Advisor and author of the Bestselling "Options Trading for Dummies," now in its 4th edition and several other books including "Market Timing for Dummies" and "Successful Biotech Investing". Although Joe's favorite areas of the market are technology and healthcare, he is a versatile investor who enjoys finding that hidden gem stock before the crowd, no matter what the sector. He is an original CNBC Market Maven, and is visible regularly on Stockcharts.TV. He has published articles on Marketwatch.com and has been widely quoted in the major media including The Wall Street Journal and Barron’s magazine.
Analyst Articles
For now, I am recommending closing our current Texas Instruments based trade out before the Federal Reserve’s interest rate hike and Chairman Powell’s press conference. Read More
The construction of 3-D printer homes is the cutting edge in housing. Here's how to cash in. Read More
I recommended the sale of the Texas Instruments (NSDQ: TXN) December 16, 2022 $170 Put Option on 12/1/22 with the condition that the trade should be done as long as the share price was above $175. Read More
As promised during yesterday's interim update, I have a new trade. Read More
Our in-house "technician" explains why he relies on the wisdom of charts, which are reliable predictors of future movements. Read More
The market is on pins and needles about the Federal Reserve right now. And with Fed Chairman Powell speaking this afternoon, I don’t want to take any chances. Read More
Sometimes the best investment advice can be found off Wall Street. Here are three classic Yogi-isms to apply to your investing plan. Read More
We're letting our Home Depot put options expire worthless for a maximum profit. I'm also recommending a new trade on Microsoft. Read More
With the end of the year approaching, it's a good time for a roundup of the major portfolio moves we made in 2022. Read More